Traditionally, vaccine manufacture has accounted for a huge amount of aseptic production. In recent years, there has been a larger focus on novel biologic therapies, of which the majority are ...

Craig is the founder/CEO of compliance operations software company Hyperproof and an expert in the compliance, risk, and technology space. In today’s volatile environment, organizations need to have ...

While some wearables may be tailor made for trial use, they face challenges translating to real-world patient applications outside of a stringent trial setting, and vice versa. This creates a unique ...

Tia Harmon (left) is a Technical Product Sales Specialist in the cell and gene therapy (CGT) space at PHC Corporation of North America (PHCNA; IL, USA) with a background in cancer research. In this ...